谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Multicenter, Phase 1 Study of Etavopivat (FT-4202) Treatment for Up to 12 Weeks in Patients with Sickle Cell Disease

Santosh L. Saraf,Robert Hagar,Modupe Idowu,Ifeyinwa Osunkwo,Kimberly Cruz,Frans A. Kuypers,R. Clark Brown,James Geib,Maria Ribadeneira,Patricia Schroeder,Eric Wu,Sanjeev Forsyth,Patrick F. Kelly,Theodosia A. Kalfa,Marilyn J. Telen

Blood advances（2024）

引用 0|浏览19
暂无评分
关键词
Etavopivat,pyruvate kinase,2,3-diphosphoglycerate,sickle cell disease,hemoglobin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要